Safety and efficacy of topical nitroglycerin for treatment of vulvar pain in women with vulvodynia: A pilot study

Journal of Gender-Specific Medicine

Volumn 5, Issue 4, 2002, Pages 21-27

  Walsh, Kathleen E ^a   Berman, Jennifer R ^b   Berman, Laura A ^b   Vierregger, Kristen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYPOTENSION; MUSCLE WEAKNESS; PAIN ASSESSMENT; QUESTIONNAIRE; RATING SCALE; SEXUAL BEHAVIOR; SEXUALITY; TREATMENT OUTCOME; VERTIGO; VULVODYNIA;

ADMINISTRATION, TOPICAL; ADULT; FEMALE; HUMANS; MIDDLE AGED; NITROGLYCERIN; PAIN; PILOT PROJECTS; VASODILATOR AGENTS; VULVA; VULVAR DISEASES;

EID: 0036663526     PISSN: 15237036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Goetsch MF Vulvar vestibulitis: Prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991;164(6 Pt 1):1609-1614.
2. McKay M. Subsets of vulvodynia. J Reprod Med 1988;33(8):695-698.
3. McKay M. Vulvodynia: Diagnostic patterns. Dermatol Clin 1992;10(2):423-433.
4. Spadt SK. Suffering in silence: Managing vulvar pain patients. Contemporary Nurse Practitioner 1995;1(6):32-38.
5. Ashman RB, Ott AK. Autoimmunity as a factor in recurrent vaginal candidosis and the minor vestibular gland syndrome. J Reprod Med 1989;34(4):264-266.
6. Scrimin F, Volpe C, Tracanzan G, et al. Vulvodynia and selective IgA deficiency: Case reports. Br J Obstet Gynaecol 1991;98(6):592-593.
7. Witkin SS. Immunology of recurrent vaginitis. Am J Reprod Immunol Microbiol 1987;15(1):34-37.
8. Paavonen J. Diagnosis and treatment of vulvodynia. Ann Med 1995;27(2):175-181.
9. Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis: A case report. J Reprod Med 1991;36(12):879-882.
10. Jones KD, Lehr ST. Vulvodynia: Diagnostic techniques and treatment modalities. Nurse Pract 1994; 19(4):34-46.
11. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: A physiologic messenger. Ann Intern Med 1994; 120(3):227-237.
12. Ferreira J, Santos AR, Calixto JB. The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice. Neuropharmacology 1999;38(6):835-842.
13. Tao YX, Hassan A, Haddad E, Johns RA. Expression and action of cyclic GMP-dependent protein kinase I alpha in inflammatory hyperalgesia in rat spinal cord. Neuroscience 2000;95(2):525-533.
14. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, patho-physiology, and pharmacology. Pharmacol Rev 1991;43(2):109-142.
15. Gorfine SR. Treatment of benign anal disease with topical nitroglycerin. Dis Colon Rectum 1995;38(5):453-456.
16. Hechtman HB, Barlow C. Moderation of anal sphincter tone with nitric oxide agonists and antagonists. Arch Surg 1996;131(7):775-784.
17. Pittrof R, Lees C, Thompson C, et al. Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhea. BMJ 1996;312(7035):884.
18. Li Wan Po A, Stones RW. Transdermal glyceryl trinitrate for dysmenorrhea: Confidence intervals for glyceryl trinitrate do not suggest a significant effect. BMJ 1996;313(7053):364.
19. Smith SD, Wheeler MA, Foster HE Jr, Weiss RM. Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 1996;155(4):1432-1435.
20. Ehren I, Iversen H, Jansson O, et al. Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses. Urology 1994;44(5):683-687.
21. Smith SD, Wheeler MA, Weiss RM. Nitric oxide synthase: An endogenous source of elevated nitrite in infected urine. Kidney Int 1994;45(2):586-591.
22. Wheeler MA, Smith SD, Garcia-Cardena G, et al. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997;99(1):110-116.
23. Irazuzta JE, McManus ML. Use of topically applied nitroglycerin in the treatment of purpura fulminans. J Pediatr 1990;117(6):993-995.
24. Meyer MT, Irazuzta JE, Tozibikian H. Topical nitroglycerin and pain in purpura fulminans. J Pediatr 1999;134(5):639-641.
25. Irazuzta JE, Jarrell J, Portillo A, Klapproth KL. Compared contralateral application of topical nitroglycerin on purpura fulminans. W V Med J 1998;94(1):29-30.
26. Berrazueta JR, Losada A, Poveda I, et al. Successful treatment of shoulder pain syndrome due to supraspinatus tendinitis with transdermal nitroglycerin: A double blind study. Pain 1996;66(1):63-67.
27. Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999;60(2):508-514.
28. Dubin NH, Wolff MC, Thomas CL, DiBlasi MC. Prostaglandin production by rat vaginal tissue, in vitro, in response to ethanol, a mild mucosal irritant. Toxicol Appl Pharmocol 1985;78(3):A58-463.
29. Shahed AR, Shoskes DA. Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 2001;166(5):1738-1741.
30. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987;139(1):19-30.
31. Moncada S, Higgs EA. Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991;21:361-374.
32. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: A physiologic messenger. Ann Intern Med 1994;120(3):227-237.
33. Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: Cytotoxicity versus cytoprotection: How, why, when, and where? Nitric Oxide 1997;1(2):107-120.
34. Durate ID, Lorenzetti BB, Ferreira SH. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 1990;186(2-3):289-293.